728 related articles for article (PubMed ID: 11290872)
21. Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Kusakabe H; Iwasaki H; Sano K; Kiyokane K
Arch Dermatol Res; 2000 Jun; 292(6):292-300. PubMed ID: 10929770
[TBL] [Abstract][Full Text] [Related]
22. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
23. Expression of multidrug resistance-related transporters in human breast carcinoma.
Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
25. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma.
Schwarzenbach H
Med Oncol; 2002; 19(2):87-104. PubMed ID: 12180485
[TBL] [Abstract][Full Text] [Related]
26. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells.
Wada H; Saikawa Y; Niida Y; Nishimura R; Noguchi T; Matsukawa H; Ichihara T; Koizumi S
Exp Hematol; 1999 Jan; 27(1):99-109. PubMed ID: 9923448
[TBL] [Abstract][Full Text] [Related]
27. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
[TBL] [Abstract][Full Text] [Related]
29. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes.
Ikeda K; Oka M; Yamada Y; Soda H; Fukuda M; Kinoshita A; Tsukamoto K; Noguchi Y; Isomoto H; Takeshima F; Murase K; Kamihira S; Tomonaga M; Kohno S
Int J Cancer; 1999 Aug; 82(4):599-604. PubMed ID: 10404077
[TBL] [Abstract][Full Text] [Related]
30. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
31. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
32. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
[TBL] [Abstract][Full Text] [Related]
34. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
36. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
37. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
Ax W; Soldan M; Koch L; Maser E
Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
[TBL] [Abstract][Full Text] [Related]
38. Differential expression and activity of P-glycoprotein and multidrug resistance-associated protein in CD34-positive KG1a leukemic cells.
Fardel O; Payen L; Courtois A; Drenou B; Fauchet R; Rault B
Int J Oncol; 1998 Feb; 12(2):315-9. PubMed ID: 9458355
[TBL] [Abstract][Full Text] [Related]
39. The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.
Hu WQ; Peng CW; Li Y
J Exp Clin Cancer Res; 2009 Nov; 28(1):144. PubMed ID: 19930704
[TBL] [Abstract][Full Text] [Related]
40. [Establishment of in vivo adriamycin-induced multidrug resistance models of subcutaneous and hepatic transplanted human liver cancer in nude mice].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Ai Zheng; 2004 Aug; 23(8):905-9. PubMed ID: 15301712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]